GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » EV-to-FCF

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) EV-to-FCF : 0.00 (As of May. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ginkgo Bioworks Holdings's Enterprise Value is $0.00 Mil. Ginkgo Bioworks Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-336.30 Mil. Therefore, Ginkgo Bioworks Holdings's EV-to-FCF for today is 0.00.

The historical rank and industry rank for Ginkgo Bioworks Holdings's EV-to-FCF or its related term are showing as below:

DNA.WS' s EV-to-FCF Range Over the Past 10 Years
Min: -78.39   Med: -8.23   Max: -2.39
Current: -3.2

During the past 5 years, the highest EV-to-FCF of Ginkgo Bioworks Holdings was -2.39. The lowest was -78.39. And the median was -8.23.

DNA.WS's EV-to-FCF is ranked worse than
100% of 390 companies
in the Biotechnology industry
Industry Median: 6.365 vs DNA.WS: -3.20

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Ginkgo Bioworks Holdings's stock price is $0.05. Ginkgo Bioworks Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000. Therefore, Ginkgo Bioworks Holdings's PE Ratio for today is N/A.


Ginkgo Bioworks Holdings EV-to-FCF Historical Data

The historical data trend for Ginkgo Bioworks Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings EV-to-FCF Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -38.43 -7.63 -7.97

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.63 -4.53 -7.97 -7.22 -7.97

Competitive Comparison of Ginkgo Bioworks Holdings's EV-to-FCF

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's EV-to-FCF falls into.



Ginkgo Bioworks Holdings EV-to-FCF Calculation

Ginkgo Bioworks Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-336.301
=0.00

Ginkgo Bioworks Holdings's current Enterprise Value is $0.00 Mil.
Ginkgo Bioworks Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-336.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ginkgo Bioworks Holdings  (NYSE:DNA.WS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ginkgo Bioworks Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.05/0.000
=N/A

Ginkgo Bioworks Holdings's share price for today is $0.05.
Ginkgo Bioworks Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ginkgo Bioworks Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.